Interaction between vitamin D receptor and vitamin D ligands: Two-dimensional alanine scanning mutational analysis

被引:46
作者
Choi, M
Yamamoto, K
Itoh, T
Makishima, M
Mangelsdorf, DJ
Moras, D
DeLuca, HF
Yamada, S
机构
[1] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan
[2] Osaka Univ, Dept Organismal Biosyst, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan
[3] Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA
[4] CNRS, Lab Biol & Genom Struct, IGBMC, F-67404 Illkirch Graffenstaden, France
[5] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
来源
CHEMISTRY & BIOLOGY | 2003年 / 10卷 / 03期
关键词
D O I
10.1016/S1074-5521(03)00050-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We present a new method to investigate the details of interaction between vitamin D nuclear receptor (VDR) and various ligands, namely a two-dimensional alanine scanning mutational analysis. In this method, the transactivation of various ligands is studied in conjunction with a series of alanine scanning mutations of the residues lining the ligand binding pocket (LBP) of VDR, and the complete set of results is profiled in a patch table. We investigated examples from four structurally diverse groups of known VDR ligands: the native vitamin D hormone and two compounds with the same side chain configuration; four 20-epi compounds; three 19-nor compounds; and two nonsecosteroids. The patch table of the results indicates characteristics of each group in terms of its interaction with 18 LBP residues. We demonstrate the validity of this approach by application to docking studies of the two nonsecosteroids.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 33 条
[1]   20-EPI-VITAMIN-D3 ANALOGS - A NOVEL CLASS OF POTENT REGULATORS OF CELL-GROWTH AND IMMUNE-RESPONSES [J].
BINDERUP, L ;
LATINI, S ;
BINDERUP, E ;
BRETTING, C ;
CALVERLEY, M ;
HANSEN, K .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (08) :1569-1575
[2]   Ligand recognition by the vitamin D receptor [J].
Choi, MW ;
Yamamoto, K ;
Masuno, H ;
Nakashima, K ;
Taga, T ;
Yamada, S .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (07) :1721-1730
[3]  
DeLuca H. F. J., 1990, J BONE MINER METAB, V8, P1
[4]  
DELUCA HF, 2002, Patent No. 6440953
[5]   THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY [J].
EVANS, RM .
SCIENCE, 1988, 240 (4854) :889-895
[6]   Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy [J].
Geller, DS ;
Farhi, A ;
Pinkerton, N ;
Fradley, M ;
Moritz, M ;
Spitzer, A ;
Meinke, G ;
Tsai, FTF ;
Sigler, PB ;
Lifton, RP .
SCIENCE, 2000, 289 (5476) :119-123
[7]  
KOBAYASHI T, 1993, BIOORG MED CHEM LETT, V3, P185
[8]  
Kragballe K., 1997, Vitamin D., P1213
[9]  
Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO
[10]  
2-8